Home News

Biogen R&D Day to Provide Overview of Diversified Pipeline and Capabilities with Potential for Multiple Novel Therapies in Neuroscience

September 24, 2021

Biogen Inc. (Nasdaq: BIIB) will hold a virtual Investor R&D Day today, providing a comprehensive overview of the company’s diversified pipeline …

Read the source article at Send Press Releases with GlobeNewswire
2021-09-21 16:30:00

Advantages of Early Minimally Invasive Surgery for Intracerebral Hemorrhage

Advantages of Early Minimally Invasive Surgery for Intracerebral Hemorrhage

April 11, 2024

Ionis Pharma Advances Olezarsen Towards Launch for Rare Disease Treatment Following Promising Trial Results

Ionis Pharma Advances Olezarsen Towards Launch for Rare Disease Treatment Following Promising Trial Results

April 9, 2024

Study Links GLP-1 Diabetes and Obesity Drugs to Increased Risk of Aspiration Pneumonia Post-Endoscopy

Study Links GLP-1 Diabetes and Obesity Drugs to Increased Risk of Aspiration Pneumonia Post-Endoscopy

March 28, 2024

Breakthrough Study Identifies Three Subtypes of Multiple Sclerosis Based on Immune Markers

Breakthrough Study Identifies Three Subtypes of Multiple Sclerosis Based on Immune Markers

March 27, 2024

GLP-1 RA Use Linked to Increased Residual Gastric Content in Fasted Patients

GLP-1 RA Use Linked to Increased Residual Gastric Content in Fasted Patients

March 7, 2024

Breakthrough in Fetal Disease Study: Viable Cells in Amniotic Fluid Offer New Research Avenues

Breakthrough in Fetal Disease Study: Viable Cells in Amniotic Fluid Offer New Research Avenues

March 4, 2024